| 27. | Satyanarayanajois, S.D., Hill, R.A. (2011). Medicinal chemistry for 2020. Future Med. Chem. 14: 1765-1786 |
| 26. | Johnson, Wilbur, Jr.; Bergfeld, Wilma F.; Belsito, Donald V.; Hill, Ronald A.; Klaassen, Curtis D.; Liebler, Daniel C.; Marks, James G., Jr.; Shank, Ronald C.; Slaga, Thomas J.; Snyder, Paul W.; et al. Amended safety assessment of Sesamum indicum (sesame) seed oil, hydrogenated sesame seed oil, Sesamum indicum (sesame) oil unsaponifiables, and sodium sesameseedate. International Journal of Toxicology (2011), 30(Suppl. 1), 40S-53S. [and 4 other similar publications from the same group so far in 2011] |
| 25. | Becker, Lillian C.; Bergfeld, Wilma F.; Belsito, Donald V.; Hill, Ronald A.; Klaassen, Curtis D.; Liebler, Daniel C.; Marks, James G., Jr.; Shank, Ronald C.; Slaga, Thomas J.; Snyder, Paul W.; et al. Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics. International Journal of Toxicology (2010), 29(Suppl. 4), 288S-305S. [and 6 other similar publications from the same group in 2010] |
| 24. | Khanfar MK, Hill RA, Kaddoumi A, El Sayed KA.* 2010. Combined ligand and structure-based virtual screening for identification of novel GSK-3β inhibitors with potent in vitro and in vivo activities and excellent brain permeability. J Med. Chem. 53(24), 8534-8545 |
| 23. | Hill, Ronald A. Chapter 20: Hormone-Related Disorders–Nonsteroidal Therapies. In: Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, 12th edit. John H. Block, John M. Beale, Jr., Eds., 2010. |
| 22. | Zharikova, O. L.; Fokina, V. M.; Nanovskaya, T. N.; Hill, R. A.; Mattison, D. R.; Hankins, G. D. V.; Ahmed, M. S.* Identification of the major human hepatic and placental enzymes responsible for the metabolism of glyburide. Biochemical Pharmacology, 2009, 78(12), 1483-1490. |
| 21. | Devarakonda, B.; Otto, D. P.; Judefeind, A.; Hill, R. A.; de Villiers, M. M.* Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. International Journal of Pharmaceutics, 2007, 345, 142–153. |
| 20. | Zharikova, O. L.; Ravindran, S.; Nanovskaya, T. N.; Hill, R. A.; Hankins, Gary D. V.; Ahmed, M. S.* Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon. Biochemical Pharmacology 2007, 73, 2012–2019. |
| 19. | Schulte, Marvin K.;* Hill, Ronald A.;* Bikádi, Zsolt;* Maksay, Gábor; Parihar, Harish S.; Joshi, Prasad; Suryanarayanan, Asha. The structural basis of ligand interactions in the 5-HT3 receptor binding site. In Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies. Arias, Hugo R., editor. (Research Signpost Press, 2006, ISBN 81-7736-254-2), pp 127–154. |
| 18. | Chilakapati, J., Korrapati, M.C., Hill, R.A., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. Role of thioacetamide sulfoxide in saturation of toxicokinetics of thioacetamide. Toxicology 2007, 230, 105-116 |
| 17. | Chilakapati, J., Korrapati, M.C., Shankar, K., Hill, R.A., Warbritton, A., Latendresse, J.R.and Mehendale, H.M. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: effects of diet restriction and phenobarbital. Toxicol. Appl. Pharmacol. 2007, 219, 72-84 |
| 16. | Selvan, R.; Zharikova, O. L.; Hill, R. A.; Nanovskaya, T. N.; Hankins, G. D. V.; Ahmed, M. S.* Identification of Glyburide Metabolites formed by Hepatic and Placental Microsomes of Humans and Baboons. Biochemical Pharmacology 2006, 72(12), 1730-1737. |
| 15. | Devarakonda, B.; Hill, R. A.; Liebenberg, W.; Brits, M.; De Villiers, M. M.* Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. International Journal of Pharmaceutics, 2005, 304, 193–209 |
| 14. | Chilikapati, J.; Shankar, K.; Korrapati, M. C.; Hill, R. A.; Mehendale, H. M.* Saturation Toxicokinetics of Thioacetamide: Role in Development of Liver Injury. Drug Metab. Dispos., 2005, 33, 1877–1885. |
| 13. | Liu, D. L.; Hill, R. A.* Treatment of Certain ortho-Substituted Benzaldehydes with Nitronium Tetrafluoroborate in Acetonitrile Yields Nitrated a,a-Bisacetamido Toluenes. J. Org. Chem., in revision. |
| 12. | Devarakonda, B.; Hill, R. A.; de Villiers, M. M.* The Effect of PAMAM Dendrimer Generation Size and Surface Functional Group on the Aqueous Solubility of Nifedipine. Int. J. Pharm., 2004, 284(1–2), 133–140 |
| 11. | Hill, R. A.* Rudra, S.; Peng, B.; Roane, D. S.; Bounds, J. K.; Zhang, Y.; Adloo, A. A; Lu, T. Hydroxyl-Substituted Sulfonylureas as Potent Inhibitors of Specific [3H]Glyburide Binding to Rat Brain Synaptosomes. Bioorg. Med. Chem., 2003, 11, 2099-2113. |
| 10. | Goskonda, V. R.; Hill, R. A.; Khan, M. A.; Reddy, I. K.* Permeability of Chemical Delivery Systems Across Rabbit Corneal (SIRC) Cell Line and Isolated Corneas: A Comparative Study. Pharm. Dev. Technol. 2000, 5, 409–416. |
| 9. | Wu, J.; Barrois, M. J.; Zhou, L. H.; Ace, L. N., Jr.;* Liu, D. L.; Danthi, S. N.; Hill, L. J.; Hill, R. A.* Potential Prodrugs of a Triply-Ionized a-Amino Acid AMPA Antagonist: Biotransformation in Rat Brain Homogenates and Preliminary In Vivo Studies. In active preparation for J. Pharm. Sci.; partial abstract published: AAPS PharmSci. 1999, 4, S515.) |
| 8. | Bhat, A.; Chang, H.-M.; Wallace, L. J.; Weinstein, D. M.; Shams, G.; Garris, C. C.; Hill, R. A.* 1,4-Dihydro-2,3-quinoxalinediones as Potential Flavin Metabolites and Excitatory Amino Acid Receptor Ligands. I. Synthesis and Pharmacological Evaluation of the Benzylic Oxidation Series of 1,4-Dihydro-6,7-dimethyl-2,3-quinoxalinedione. Bioorg. Med. Chem.1998, 6, 271–282. |
| 7. | Danthi, S. N.; Hill, R. A.* Synthesis of chirally pure 2,5-disubstituted diketopiperazines derived from trisubstituted phenylalanines. J. Heterocycl. Chem. 1997, 34, 835–844. |
| 6. | Hill, R. A.; Wallace, L. J.; Miller, D. D.*; Tai, H.; Layer, R. T.; Weinstein, D.; Willins, D. L.; Uretsky, N. J. Structure-activity Studies for a-Amino-3-hydroxy-5-methyl-4-isoxazolepropanoic Acid Receptors: Acidic Hydroxyphenylalanines. J. Med. Chem. 1997, 40, 3182–3191. |
| 5. | Yamreudeewong, W.*; Danthi, S. N.; Hill, R. A.* Stability of Ondansetron for Injection Admixtures with Various Beverages for Oral Administration. Am. J. Health-Syst. Pharm. 1995, 52, 2011–2014. |
| 4. | Hill, R. A.; Labanowski, J. K.*; Heisterberg, D. J.; Miller, D. D.* Formic Acid: Methylamine Complex Studied by the Hartree-Fock and Density Functional Approaches. In Density Functional Methods in Chemistry (Springer-Verlag: New York, 1991) pp. 357–372. |
| 3. | Ronald A. Hill. Part 1. Design, Synthesis, and Structure-Activity Studies of Molecules with Activity at Non-NMDA Glutamate Receptors: Hydroxyphenylalanines, Quinoxalinediones and Related Molecules. Part 2. Computational Studies on the Interaction of the Dopamine Amino Group and Amino Group Replacements with Carboxylate Anions as a Model for Receptor Interactions. Ph.D. Dissertation, The Ohio State University, Columbus, Ohio, 1991. |
| 2. | Hill, R. A.; Snider, B. G.*; Rosanske, T. W.* A widely applicable automated sampling apparatus for dissolution testing. Int. J. Pharm. 1987, 36, 175–183. |
| 1. | Cox, S. R.*; Harrington, E. L.; Hill, R. A.; Capponi, V. J.; Shah, A. C. Bioavailability Studies with Ciglitazone in Beagles. 1. Effect of a Meal on the Bioavailability of Three Ciglitazone Dosage Forms. Biopharm. and Drug Dispos. 1985, 6, 67–80. |
Professional Presentations and Published Abstracts
| 45. | Invited Presentation: A Sulfonylurea Saga. Presented in the College of Pharmacy, Southern Illinois University - Edwardsville, November 14, 2008. |
| 44. | Ravindran, S.; Zharikova, O.; Nanovskaya, T.; Hill, R. A.; Mattison, D.; Hankins, G.; Ahmed, M.. Investigation of glyburide and its metabolites in urine and plasma of pregnant patients under treatment for gestational diabetes. Abstracts of Papers, 235th ACS National Meeting, New Orleans, LA, United States, April 6-10, 2008, MEDI-132. |
| 43. | Ravindran, Selvan; Zharikova, O. L.; Hill, R. A.; Nanovskaya, T. N.; Hankins, G. D. V.; Ahmed, M. S. Identification of glyburide metabolites formed by baboon hepatic and placental microsomes using HPLC-MS. Abstracts, 62nd Southwest Regional Meeting of the American Chemical Society, Houston, TX, United States, October 19-22 (2006) |
| 42. | Ravindran, Selvan; Zharikova, Olga L.; Hill, Ronald A.; Nanovskaya, Tatiana N.; Hankins, Gary D. V.; Ahmed, Mahmoud S.* Metabolism of Glyburide by Microsomes from Human Liver and Placenta: A Study by HPLC-MS. Abstract MEDI 56, poster presented at the 231st American Chemical Society National Meeting, March 26, 2006, Atlanta, GA |
| 41. | Harish S. Parihar, Karen S. Kirschbaum,* Mark E. Arant, and Ronald A. Hill* General Synthetic Route for Preparation of d-Tubocurarine Fragment Molecules: Probing the 5-HT3R and nAChR MALTO Medicinal Chemistry Meeting, Memphis, TN, May 17, 2004. |
| 40. | Parihar, H. S.; Kirschbaum, K. S.;* Hill, Ronald A.* New Synthetic Route to d-Tubocurarine Fragment Molecules. Abstract MEDI 284, poster presented at the 227th American Chemical Society National Meeting, March 31, 2004, Anaheim, CA |
| 39. | Bharathi Devarakonda, Ronald A. Hill, and Melgardt M. deVilliers.* Solubilization of the Poorly Water Soluble Drug Nifedipine by Poly(Amidoamine) Dendrimers. Poster Abstract #6, presented at the 30th Annual MALTO Medicinal Chemistry Meeting, Little Rock, AR, May 18, 2003. |
| 38. | J. Chilakapati, K. Shankar, R.A. Hill, and H.M. Mehendale.* Toxicokinetics of thioacetamide explains lack of dose-response for liver injury in ad libitum and diet-restricted rats. The Toxicologist 2003, 72, 199 |
| 37. | Bharathi Devarakonda, Ronald A. Hill, and Melgardt M. deVilliers.* Solubilization of the Poorly Water Soluble Drug Nifedipine by Poly(Amidoamine) Dendrimers. Poster Abstract #6, presented at the 30th Annual MALTO Medicinal Chemistry Meeting, Little Rock, AR, May 18, 2003. |
| 36. | J. Chilakapati, K. Shankar, R. A. Hill, and H. M. Mehendale.* Saturable Toxicokinetics of Thioacetamide Explains Lack of Dose-Response for Liver Injury. Poster #32, American College of Toxicology 23rd Annual Meeting, November, 2002, Hershey, PA; Int. J. Toxicol. 2002, 21, 523. |
| 35. | Jian Guo, Harihara M. Mehendale, and Ronald A. Hill.* Reactions of thioacetamide, thioacetamide S-oxide, and acetamide with 2,3-dichloroquinoxalines: investigations of the reactions of reactions of aminosulfines with bivalent electrophiles, and a quest for fluorescent derivatives for the study of thioacetamide metabolism. Podium presentation at the 29th Annual MALTO Medicinal Chemistry Meeting, Monroe, LA, May 20, 2002. |
| 34. | Jian Guo, Harihara M. Mehendale, and Ronald A. Hill.* Reactions of thioacetamide, thioacetamide S-oxide, and acetamide with 2,3-dichloroquinoxalines: novel reactions of aminosulfines, and fluorescent derivatives for the study of thioacetamide metabolism. Abstract MEDI 93, poster presented at the 223rd American Chemical Society National Meeting, April 12, 2002, Orlando, FL. |
| 33. | Invited Presentation: Prodrug and Bioprecursor Strategies for Delivery of an Acidic Amino Acid Antagonist to the Brain. Presented in the Department of Chemistry, McNeese State University, Lake Charles, LA, April 4, 2001. |
| 32. | Invited Presentation: Bioprecursors and Prodrugs of an Acidic a-Amino Acid: Towards Improved Efficacy and Pharmacotherapeutic Selectivity of Excitatory Amino Acid Receptor Ligands. Presented in the Department of Basic Pharmaceutical Sciences Spring Seminar Series, College of Pharmacy, The University of Louisiana at Monroe, Monroe, LA, March 29, 2001. |
| 31. | Donglei Liu, Satyavijayan N. Danthi, and Ronald A. Hill.* Strategies for Delivery of an Acidic Amino Acid AMPA Antagonist to the Brain: Continued Pursuit of Latentiated a-Keto Acid Prodrugs. Abstract MEDI 210, poster presented at the 220th American Chemical Society National Meeting, August 23, 2000, Washington, DC. |
| 30. | Donglei Liu, Jing Wu, Louis N. Ace, and Ronald A. Hill.* Synthesis of Potential Prodrugs of a Triply-Ionized a-Amino Acid AMPA Antagonist. Abstract #17, poster presented at the 27th Annual MALTO Medicinal Chemistry Meeting, New Orleans, LA, May 22, 2000. |
| 29. | H. M. Mehendale*, V. S. Vaidya, and R. A. Hill. Toxicokinetics of Dose-Dependent Thiobenzamide Hepatotoxicity and Tissue Repair Response. Abstract #276, poster presented at the 2000 Society of Toxicology Annual Meeting, 20 March 2000, Philadelphia, PA. The Toxicologist 2000, 54, 276. |
| 28. | J. Wu, M. J. Barrois, L. H. Zhou, L. N. Ace, Jr.,* D. Liu, S. N. Danthi, and R. A. Hill.* Potential Prodrugs of a Triply-Ionized a-Amino Acid AMPA Antagonist: Biotransformation in Rat Brain Homogenates. Abstract #3555, poster presented at the American Association of Pharmaceutical Scientists Annual Meeting, 17 November 1999, New Orleans, LA. (AAPS PharmSci. 1999, 4, S515.) |
| 27. | Vishal S. Vaidya, Udayan M. Apte, Kartik Shankar, Madhusudan G. Soni, Ronald A. Hill, and Harihara M. Mehendale.* Thiobenzamide-Induced Mortality Is Sixfold Greater In Sprague-Dawley Rats With Twofold Higher Body Weight. Platform presentation at the 9th North American ISSX Meeting, Nashville, Tennessee, 1999. ISSX Proceedings, 1999, 15, 399. |
| 26. | Donglei Liu and Ronald Hill.* Treatment of Certain o-Substituted Benzaldehydes with Nitronium Tetrafluoroborate in Acetonitrile Yields Nitrated a,a-Bisacetamido Toluenes. Abstract ORGN 524, poster presented at the 218th American Chemical Society National Meeting, August 25, 1999, New Orleans, LA. |
| 25. | Donglei Liu, Satyavijayan N. Danthi, and Ronald A. Hill.* Progress towards the Synthesis of Latentiated a-Keto Acid and a-Keto Ester Prodrugs of a Triply-Ionized Amino Acid AMPA Antagonist. Poster presented at the 26th Annual MALTO Medicinal Chemistry Meeting, Memphis, Tennessee, May 23, 1999. |
| 24. | Wu Jing, Monique J. Barrois, Lucy Hua Zhou, Louis N. Ace, Jr.,* Donglei Liu, Satyavijayan N. Danthi, and Ronald A. Hill.* Potential Prodrugs of a Triply-Ionized a-Amino Acid AMPA Antagonist: Biotransformation in Rat Brain Homogenates. Abstract #11, poster presented at the 2nd Annual American Association of Pharmaceutical Scientists Southern Regional Discussion Group, May 21, 1999. |
| 23. | Invited Presentation: Activity of Naturally Occurring 2,3-Qunioxalinediones in Excitatory Amino Acid Neurotransmitter Systems: Possible Links to Riboflavin (Vitamin B2) Metabolism, University of Southwestern Louisiana Department of Chemistry, April 16, 1999. |
| 22. | Olivier, R.; Hill, R.; Pope, C.* Glucose Feeding Increases Bioactivation and Neurotoxicity of Parathion. Presented at the South Central Chapter of the Society of Toxicology, Little Rock, AR, September 1997. |
| 21. | S. N. Danthi, J. Zhang, F. R. Abadie, and R. A. Hill.* Continued Development of Bioprecursors for Amino Acid AMPA Antagonists: Morpholinediones and a-Keto Acids. Abstract MEDI 39, poster presented at the 213th American Chemical Society National Meeting, April 1997. |
| 20. | Invited Presentation: Naturally Occurring 1,4-Dihydro-2,3-Quinoxalinediones are Excitatory Amino Acid Receptor Ligands; Possible Relationships to Riboflavin Metabolism. Presented in the Department of Medicinal Chemistry and Pharmacognosy at The Ohio State University College of Pharmacy, Columbus, Ohio, Nov. 6, 1996. |
| 19. | H.-M. Chang, Jan Chen, Ajita Bhat, Yanyun Chen, Lane J. Wallace, Gamal Shams, David Weinstein, and Ronald Hill.* 2,3-Quinoxalinediones as Potential Flavin Metabolites and as Excitatory Amino Acid Receptor Ligands. Abstract MEDI 73, poster presented at the 212th American Chemical Society National Meeting, August 25, 1996, Orlando, FL. |
| 18. | S. N. Danthi and R. A. Hill.* Synthesis of Cyclic Peptides as Lipophilic Bioprecursors for the Delivery of Amino Acids to the Brain. 23rd Annual MALTO Medicinal Chemistry Meeting, Oxford, MS, May 20, 1996. |
| 17. | H.-M. Chang, J. Chen, A. Bhat, Y. Chen, L. J. Wallace, G. Shams, D. Weinstein, and R. A. Hill.* Synthesis, Bioactivity, and Natural Occurrence in Rodents of 2,3-Quinoxalinediones as Potential Flavin Metabolites. 23rd Annual MALTO Medicinal Chemistry Meeting, Oxford, MS, May 21, 1996. |
| 16. | S. N. Danthi, Y. S. Chen, and R. A. Hill.* Stereospecific Synthesis of 2,5-Disubstituted Diketopiperazines as Bioprecursors of an Amino Acid AMPA Antagonist in the Brain. Abstract MEDI 156, poster presented at the 210th American Chemical Society National Meeting, Chicago, IL, August 23, 1995. |
| 15. | Invited Presentation: Design and Evaluation of AMPA Antagonists in a Model for Drug Dependence, and Strategies for Brain-Region-Selective Delivery. Presented in the Department of Pharmacology at Louisiana State University Medical Center, New Orleans, Louisiana, May 25, 1995. |
| 14. | Sonali Rudra, Ronald A. Hill,* and David S. Roane. Synthesis of Hydroxyl-Substituted Sulfonylureas: Towards the Development of CNS-Selective ATP-Sensitive Potassium Channel Modulators. Abstract MEDI 158, poster presented at the 208th American Chemical Society National Meeting, Washington, DC, August 24, 1994. |
| 13. | Sonali Rudra, Ronald A. Hill,* and David S. Roane. Synthesis of Hydroxyl-Substituted Sulfonylureas: Towards the Development of CNS-Selective ATP-Sensitive Potassium Channel Modulators. Paper presented at the 21st Annual MALTO Medicinal Chemistry Meeting, Houston, TX, May 24, 1994. |
| 12. | Ajita Rao, Ronald A. Hill,* and Lane J. Wallace. Synthesis of Quinoxalinediones as Potential Flavin Metabolites and Ligands for Excitatory Amino Acid Receptors. Abstract MEDI 185, poster presented at the 206th American Chemical Society National Meeting, Atlanta, GA, August, 1993. |
| 11. | Ajita Rao, and Ronald A. Hill.* Synthesis of Quinoxalinediones as Possible Flavin Metabolites with Potential for Activity in Excitatory Amino Acid Neurotransmitter Systems. Paper presented at the 20th MALTO Medicinal Chemistry and Pharmacognosy Meeting, Monroe, LA, May 17, 1993. |
| 10. | Weeranuj Yamreudeewong,* S. N. Danthi, and R. A. Hill.* Stability of Ondansetron (an Injectable Dosage Form) in Apple Juice for Oral Administration. A research in progress poster presented at the American Society of Hospital Pharmacy Midyear Meeting in Orlando, Florida, December 10, 1992. |
| 9. | Ronald A. Hill, Duane D. Miller,* Lane J. Wallace, Norman J. Uretsky, Rick Layer, Henry Tai, David Willins, Donna Supko, and David Weinstein. Design, Synthesis, and Structure-Activity Studies of Molecules with Activity at Non-NMDA Excitatory Amino Acid Receptors. Paper presented at the Nineteenth MALTO Medicinal Chemistry and Pharmacognosy Meeting, Little Rock, AR, May 18, 1992. |
| 8. | Ronald A. Hill, Duane D. Miller,* Lane J. Wallace, Norman J. Uretsky, Rick Layer, David Willins, Donna Supko, David Weinstein, and Henry Tai. Development of AMPA Antagonists: Nitrated Hydroxyphenylalanines and Related Compounds. Abstract MEDI 31, poster presented at the 201st annual meeting of the American Chemical Society, Atlanta, GA, April 16, 1991. |
| 7. | R. A. Hill, D. D. Miller,* L. J. Wallace, D. E. Supko, D. L. Willins, and N. J. Uretsky. Synthesis and SAR of Some 2,3-Dihydroxyquinoxalines as Glutamate Antagonists. Poster presented at the 1990 American Association of Pharmaceutical Scientists Annual Meeting, Las Vegas, Nevada, Nov. 6, 1990. |
| 6. | R. A. Hill, J. K. Labanowski,* D. D. Miller,* N. J. Uretsky, and L. J. Wallace. Computational Model for the Interaction of Permanently-Charged Dopamine Analogs with D2 Receptors. Paper presented at the 1990 American Association of Pharmaceutical Scientists Annual Meeting, Las Vegas, Nevada, Nov. 6, 1990. |
| 5. | R.A. Hill, D. D. Miller,* L. J. Wallace, R.T. Layer, D. Supko, D. Willins, D. Weinstein, and N. J. Uretsky. Development of Non-NMDA Glutamate Antagonists. Paper presented at the Twenty-Third Annual Graduate Student Minimeeting in Medicinal Chemistry, Pittsburgh, PA, June 26, 1990. |
| 4. | Ronald A. Hill, Jan K. Labanowski,* and Duane D. Miller.* Comparison of calculated binding energies of formic acid:methylamine complexes using Hartree-Fock/MP2 and Density Functional Theory. Poster presented at the Ohio Supercomputer Center International Conference on Development and Applications of Density Functional Theory, May 7, 1990. |
| 3. | D. E. Supko, R. A. Hill, N. J. Uretsky, D. D. Miller, and L. J. Wallace.* Substituted o-tyrosines and quinoxaline-2,3-diones as potential quisqualate analogs. Fed. Am. Soc. Exp. Biol. J. 1990, 4, A603. |
| 2. | Ronald A. Hill, Lane J. Wallace, Rick Layer, Duane D. Miller,* and Norman J. Uretsky. Synthesis and Preliminary Biological Evaluation of Substituted o-Tyrosines as Potential Quisqualate Analogs. Paper presented at the American Association of Pharmaceutical Scientists Annual Meeting, Atlanta, GA, October 24, 1989. |
| 1. | R. A. Hill* and B. G. Snider.* Automated Release Rate Testing of Pharmaceutical Dosage Forms. Paper presented at the Federation of Analytical Chemistry and Spectroscopy Societies Meeting, St. Louis, Missouri, Sept. 30, 1986 |
Miscellaneous Professional Manuscripts
| 2. | Doctoral Dissertation: Ronald A. Hill. Part 1. Design, Synthesis, and Structure-Activity Studies of Molecules with Activity at Non-NMDA Glutamate Receptors: Hydroxyphenylalanines, Quinoxalinediones and Related Molecules. Part 2. Computational Studies on the Interaction of the Dopamine Amino Group and Amino Group Replacements with Carboxylate Anions as a Model for Receptor Interactions. Ph.D. Dissertation (Duane D. Miller; secondary adviser Jan K. Labanowski), The Ohio State University, Columbus, Ohio, 1991 |
| 1. | Undergraduate Honors Research Thesis (with Prof. Peter A. S. Smith): Alkylation and Decomposition Reactions of N',N'-Dimethyltoluenesulfonylhydrazine. University of Michigan (Ann Arbor), May 1982. |
The following are titles of technical reports (TR) or technical memos (IOM) released
during my tenure at The Upjohn Company, May 1982–September 1986: